- Technical Note
- Open Access
Quality of tumor lysates used for pulsing dendritic cells is influenced by the method used to harvest adherent tumor cells
© Lotfi et al; licensee BioMed Central Ltd. 2011
- Received: 28 December 2010
- Accepted: 26 May 2011
- Published: 26 May 2011
Lysates from tumor cells are reported to induce maturation of dendritic cells (DCs) and are used in clinical settings for DC-based vaccination against solid tumors. Nevertheless, the maturation inducing effect of tumor lysates on DCs is discussed controversially and the efficacy of tumor vaccines varies significantly.
Using three individual adherent colorectal tumor cell lines we also faced the difficulty to obtain consistent results regarding maturation inducing effect of tumor lysates on DCs. Therefore, we compared different methods to prepare tumor cell lysate and could demonstrate that trypsinizing as a method to harvest adherent tumor cells has a significant negative impact on biologic activity of tumor lysates. Specifically, we assessed induction of maturation markers CD40, CD80, and CD86 on DCs which were treated with differently prepared lysates.
Trypsinizing is a very common way of harvesting adherent cells from culture flasks. Our results shall call investigators' attention to the enzymatic activity of trypsin degrading some possibly important proteins on the surface of cultured cells. Specifically for DC-based vaccination against tumor antigens investigators should avoid trypsin.
- Tumor Cell Lysate
- Standard Cell Culture
- Maturation Marker
- Standard Cell Culture Condition
Lysates from tumor cells are reported to induce maturation of dendritic cells (DCs) and are used as a source for tumor specific antigens [1, 2], but as the maturation inducing effect is not strong enough , cytokine cocktails are added to DC cultures which are pulsed with tumor lysate [3, 4], in the clinical setting of DC-based tumor vaccination. We aimed to enhance the effect of tumor lysate with regard to induction of DC maturation, but as reported by others  we had to face the problem that the tumor lysate rather did not induce DC maturation, in terms of upregulation of surface markers CD40, CD80, and CD86. We aimed to clarify the reason for conflicting results concerning lysate-induced DC maturation.
Based on its protease activity trypsin cleaves cell surface proteins necessary for adherence. Trypsin at concentrations between 0.25% and 0.5% is generally used to detach and to harvest adherent (tumor) cells at the cost of loss of a portion of surface antigens. Therefore, we hypothesized that trypsin may crucially impact antigenicity of tumor lysate and subsequently its biological activity.
By building a stable chelate with calcium ions ethylenediaminetetraacetic acid (EDTA) deprives cells from calcium which is crucial for cell adherence . EDTA can substitute for trypsin to detach adherent cells without interfering with expressed surface antigens.
Lysates from tumor cells harvested by trypsin do not induce expression of maturation markers on DCs
Lysates from tumor cells can induce expression of maturation markers on DCs if trypsin is replaced by EDTA
Trypsinizing is a very common way of harvesting adherent cells from culture flasks. Our results shall call investigators' attention to the enzymatic activity of trypsin degrading not only proteins associated with cell adherence but also those cell surface proteins which are crucial for recognition of tumor cells and induction of specific immune response. Specifically for DC-based vaccination against tumor antigens investigators should avoid trypsin. According to our results, we substituted for trypsin with EDTA when harvesting DCs which were supposed to be analyzed for expression of surface maturation markers by FACS, appreciating the proteolytic effect of trypsin some research group alternatively pre-incubate their DCs with ice-cold PBS for 30 to 60 minutes, making it possible to harvest the DCs without the need for further chemical treatment.
Standard cell culture conditions
As standard culture media we used phenol-red free DMEM (Gibco) supplemented with 10% human AB serum (German Red Cross Blood Services Baden-Württemberg-Hessen) and containing 100 U/ml penicillin, 100 μg/ml streptomycin (Gibco). All cells (tumor cells, monocytes, and DCs) were cultured in this media and incubated in a humidified atmosphere at 37°C with 5% CO2.
Generation of tumor cell lysates
Three colorectal tumor cell lines HCT-116, CACO-2, COLO-678 (all from DSMZ, Germany) were cultured in our standard media. Cells were splitted for further passages or harvested to generated lysates once they reached a confluency of about 90%.
Tumor cells were detached by incubating the cells at room temperature in 0.25% Trypsin (Gibco) in 0.02% EDTA (trypsin/EDTA Sigma-Aldrich) or alternatively in 0.02% EDTA alone for 5 and 15 min, respectively. In order to inactivate trypsin/EDTA, two parts of standard cell culture media [containing 10% serum] per one part of used trypsin/EDTA was added to the cell suspension. Detached cells were washed with PBS and resuspended in sterile PBS (Lonza) at a concentration of about 1 × 108 cells/ml and lysed by 5 cycles of freeze-thawing (F/T) (-80 to 37°C). The viability following treatment was assessed using trypan blue exclusion and was always below 0.1%. Lysates were spun down hard (16,300 × g) twice and the soluble supernatant was used at given concentrations.
In some experiments obtained tumor cell lysates were divided, one part was exposed to indicated concentrations of trypsin and the other part was sham treated with PBS. In order to inactivate trypsin, 100% human AB serum (2× higher volume) was added to both arms after 5 minutes. The activity of trypsin-exposed lysates was compared to its sham-treated (PBS-exposed) counterpart.
Isolation of peripheral blood mononuclear cells and purification of monocytes and autologous lymphocytes
With the permission and supervision of the Institutional Review Board (Ethical Committee) of the University of Ulm human peripheral blood mononuclear cells were purified from whole blood by density gradient centrifugation using Biocoll (Biochrom AG, Germany), monocytes were positively selected using anti-CD14 antibodies labelled with magnetic beads (Miltenyi Biotec) following the manufacturer's instructions. The purity was assessed under microscope and was at least 95%.
Generation of monocyte derived human DCs
Immature DCs (iDCs) were generated from human monocytes within 5 days in the presence of IL-4 (500 U/ml) and GM-CSF (1000 U/ml)  (both cytokines from R&D Systems). iDCs were harvested by using EDTA, resuspended in our standard media and transferred into a flat bottom 24 well plate (Nunc) at a density of 3 to 5 × 105 iDCs/well and ml. iDCs were stimulated with indicated concentrations of individual tumor cell lysates for 3 further days and harvested then by using EDTA to detach the DCs. The mixture of IFNγ (100 ng/ml), TNFα (50 ng/ml), IL1β (10 ng/ml) (all from R&D Systems), and LPS (100 ng/ml) (Sigma-Aldrich) served as positive control for induction of DC maturation.
Cell surface staining and flow cytometry
DCs were fixed in 2% paraformaldehyde (Fluka) for 20 min at room temperature, washed with PBS. Non-specific binding sites on DCs were blocked for at least 10 min with mouse whole IgG (Jackson ImmunoResearch Laboratories). Specific staining was performed for at least 1 h at room temperature or alternatively overnight at 4°C using fluorescently labelled murine anti-human CD40, CD80 and CD86 or respective isotype controls (R&D Systems). The fluorescence of stained cells was assessed using BD FACScan (BD Biosciences). At least 20,000 events were acquired in all flow cytometric analyses.
Acknowledgements and Funding
The study was funded by the University of Ulm (Bausteine) and Deutsche Gesellschaft für Transfusionsmedizin und Immunhämatologie (DGTI).
All authors concur with the submission of the manuscript with the title mentioned above. The material submitted for publication has not been previously reported and is not under consideration for publication elsewhere.
- Dubsky P, Hayden H, Sachet M, Bachleitner-Hofmann T, Hassler M, Pfragner R: Allogeneic tumor lysate can serve as both antigen source and protein supplementation for dendritic cell culture. Cancer Immunol Immunother. 2008, 57 (6): 859-870. 10.1007/s00262-007-0422-0.PubMedView ArticleGoogle Scholar
- Feng H, Zeng Y, Graner MW, Katsanis E: Stressed apoptotic tumor cells stimulate dendritic cells and induce specific cytotoxic T cells. Blood. 2002, 100 (12): 4108-4115. 10.1182/blood-2002-05-1389.PubMedView ArticleGoogle Scholar
- Hatfield P, Merrick AE, West E, O'Donnell D, Selby P, Vile R: Optimization of dendritic cell loading with tumor cell lysates for cancer immunotherapy. J Immunother. 2008, 31 (7): 620-632. 10.1097/CJI.0b013e31818213df.PubMedPubMed CentralView ArticleGoogle Scholar
- Toh HC, Wang WW, Chia WK, Kvistborg P, Sun L, Teo K: Clinical Benefit of Allogeneic Melanoma Cell Lysate-Pulsed Autologous Dendritic Cell Vaccine in MAGE-Positive Colorectal Cancer Patients. Clin Cancer Res. 2009, 15 (24): 7726-7736. 10.1158/1078-0432.CCR-09-1537.PubMedView ArticleGoogle Scholar
- Segura-Egea JJ, Jimenez-Rubio A, Rios-Santos JV, Velasco-Ortega E, Calvo-Gutierrez JR: In vitro inhibitory effect of EGTA on macrophage adhesion: endodontic implications. J Endod. 2003, 29 (3): 211-213. 10.1097/00004770-200303000-00012.PubMedView ArticleGoogle Scholar
- Lotfi R, Lotze MT: Eosinophils induce DC maturation, regulating immunity. Journal of leukocyte biology. 2008, 83: 456-460.PubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.